UNIVERSITY OF SOUTHERN CALIFORNIA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1880-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://startusc.com
Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
Phase 1
Active, not recruiting
- Conditions
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Myelodysplasia-Related ChangesTherapy-Related Acute Myeloid Leukemia
- Interventions
- Other: Laboratory Biomarker AnalysisOther: Pharmacological Study
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 53
- Registration Number
- NCT03330821
- Locations
- 🇺🇸
Los Angeles County-USC Medical Center, Los Angeles, California, United States
🇺🇸University of Arizona Cancer Center - North Campus, Tucson, Arizona, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
A Preliminary Clinical Usability Study for the Recovery Force DVT II Cuff
Not Applicable
Completed
- Conditions
- Deep Vein ThrombosisVenous Thrombosis
- Interventions
- Device: Deep Vein Thrombosis (DVT) Cuff
- First Posted Date
- 2017-11-01
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 36
- Registration Number
- NCT03328624
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
High Dose Bupropion for Smoking Cessation - Pilot Study
Phase 2
Terminated
- Conditions
- Smoking (Tobacco) AddictionSmoking CessationSmoking, TobaccoCessation, TobaccoCigarette Smoking
- Interventions
- First Posted Date
- 2017-10-31
- Last Posted Date
- 2023-07-17
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 12
- Registration Number
- NCT03326128
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
Genetics of Beta Cell Failure in Mexican Americans
Completed
- Conditions
- Gestational DiabetesPhysical ActivityAdipokinesAir PollutionGeneticsNutritionInsulin ResistanceObesityDiabetes Type 2Beta Cell Function
- First Posted Date
- 2017-10-04
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 1250
- Registration Number
- NCT03301519
5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab
Phase 3
Terminated
- Conditions
- Colorectal AdenocarcinomaStage IIIB Colorectal Cancer AJCC v7Stage IIIC Colorectal Cancer AJCC v7Stage III Colorectal Cancer AJCC v7RAS Wild TypeStage IIIA Colorectal Cancer AJCC v7Stage IV Colorectal Cancer AJCC v7Stage IVA Colorectal Cancer AJCC v7Stage IVB Colorectal Cancer AJCC v7
- Interventions
- Biological: PanitumumabOther: Quality-of-Life AssessmentOther: Laboratory Biomarker Analysis
- First Posted Date
- 2017-10-03
- Last Posted Date
- 2020-06-11
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 4
- Registration Number
- NCT03300609
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization
Not Applicable
Withdrawn
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Drug: Sulfur Hexafluoride Lipid MicrospheresDevice: Dynamic Contrast-Enhanced Ultrasound ImagingDevice: Positron Emission TomographyDevice: Computed TomographyBiological: Yttrium-90 (90Y)
- First Posted Date
- 2017-10-03
- Last Posted Date
- 2019-05-16
- Lead Sponsor
- University of Southern California
- Registration Number
- NCT03300401
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Addressing Uncontrolled Diabetes in Primary Care: A Lifestyle Redesign Approach
Not Applicable
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- Behavioral: Lifestyle Redesign
- First Posted Date
- 2017-09-26
- Last Posted Date
- 2020-03-24
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 143
- Registration Number
- NCT03293914
- Locations
- 🇺🇸
LAC+USC Primary Care Adult West Clinic, Los Angeles, California, United States
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors
Not Applicable
Terminated
- Conditions
- Cancer SurvivorNo Evidence of DiseaseStage IIA Breast CancerStage IIB Breast CancerObesityOverweightStage IIIC Breast CancerSedentary LifestyleStage I Breast CancerStage IB Breast Cancer
- Interventions
- Behavioral: Exercise InterventionOther: Laboratory Biomarker AnalysisDevice: Monitoring DeviceOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2017-09-15
- Last Posted Date
- 2020-05-12
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 23
- Registration Number
- NCT03284346
- Locations
- 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Genetic Markers of Patients With History of Pulmonary Embolism Post Total Joint Arthroplasty
- Conditions
- Pulmonary Embolism
- First Posted Date
- 2017-09-07
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 100
- Registration Number
- NCT03275610
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3
Phase 2
Terminated
- Conditions
- Cervical Squamous Cell Carcinoma In SituVulvar High Grade Squamous Intraepithelial Lesion
- Interventions
- Other: Laboratory Biomarker AnalysisDietary Supplement: MultivitaminOther: PlaceboProcedure: Therapeutic Conventional Surgery
- First Posted Date
- 2017-08-30
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 10
- Registration Number
- NCT03267680
- Locations
- 🇺🇸
University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
🇺🇸USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath